Moscow, Russia

Nataly Fetissova

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Colgate Palmolive Company. Active years: 2015.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nataly Fetissova: Innovator in Oral Compositions

Introduction

Nataly Fetissova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of oral health through her innovative research and development of oral compositions.

Latest Patents

Fetissova holds a patent for her invention titled "Oral compositions comprising propolis." This patent includes oral compositions that consist of a propolis extract, a halogenated diphenyl ether non-ionic antibacterial agent, an anionic polymeric copolymer of methyl vinyl ether and maleic anhydride, and a source of fluoride ions. The oral composition can be formulated as a mouth rinse, a dentifrice, a confectionary, a medicament, or a film. Additionally, methods for making and using these oral compositions are also provided. She has 1 patent to her name.

Career Highlights

Fetissova is currently associated with Colgate-Palmolive Company, where she continues to work on innovative solutions for oral care. Her expertise and dedication to research have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Fetissova has collaborated with notable colleagues, including Claude A Blanvalet and Pierre Lambert. These partnerships have further enhanced her research and development efforts.

Conclusion

Nataly Fetissova is a trailblazer in the field of oral compositions, with her innovative patent contributing to advancements in oral health. Her work at Colgate-Palmolive Company and collaborations with esteemed colleagues underscore her commitment to improving oral care solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…